Bausch Health reports Q4/FY2024 results but filing lacks specific financial figures

Bausch Health Companies Inc.

2024-FY EPS reported -$0.13 revenue$9,625,000,000

Filed an 8-K on Feb 19, 2025, announcing Q4 and full year 2024 results via press release.
Press release Exhibit 99.1 is referenced but not provided in the filing text; no EPS, revenue, or segment data available.
Management commentary and guidance details cannot be extracted from the appended documents.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.